U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07106008) titled 'Radiolabeled TSPO Targeted Molecular Probe in Glioma' on July 30.

Brief Summary: Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium [68Ga]-DOTA-HK-011 in inflammation imaging of glioma.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: Glioma (Any Grade) in the Brain

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Nanjing First Hospital, Nanjing Medical University

Information provided by (Responsible Party): Feng Wang, Nanjing First Hospital, Nanjing Medical University

Disclaimer: Curated by HT Syndication....